Dr. Yang is a molecular biologist and clinical microbiologist. He has extensive experience in molecular diagnostics, clinical virology, antimicrobial resistance (AMR) mechanisms and genomic epidemiology. He is also a pioneer in the clinical applications of next-generation sequencing (NGS) in infectious diseases. Dr. Yang has developed and implemented numerous cutting-edge molecular microbiological tests in the past decade, and authored or coauthored more than 70 peer-reviewed papers and 2 book chapters. Dr. Yang is one of the earliest microbiology lab directors in the U.S. and has developed and implemented clinical NGS tests for patient testing. Dr. Yang's main expertise and research interests include molecular diagnostics and innovation, clinical virology, clinical applications of NGS, transplant-related infectious diseases testing, bacterial and fungal genomics, genomic epidemiology, and antimicrobial resistance (AMR) mechanisms and genotypic prediction. Dr. Yang also works closely with international collaborators in the investigation and monitoring of global emerging infectious diseases and novel AMR mechanisms. Dr. Yang is an advocate and public speaker for vaccines, AMR, infection prevention, and preparedness for emerging pathogens in the community.